CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint BlockadeGuangchuan Wang, Sidi Chen, Lvyun Zhu et al.|Cancer Discovery|2020Cited by 143
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenibLeilei Niu, Paul B.S. Lai|Cell Death and Disease|2018Cited by 26
The efficacy of sorafenib against hepatocellular carcinoma is enhanced by 5‐aza‐mediated inhibition of<scp>ID1</scp>promoter methylationJing Meng, Leilei Niu|FEBS Open Bio|2023Cited by 2